This inventor holds 1 USPTO granted patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Eloisa Jimenez Núnez: Innovator in Medicinal Chemistry
Introduction
Eloisa Jimenez Núnez is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the treatment of various diseases. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to improving healthcare.
Latest Patents
Eloisa holds a patent for "Substituted oxopyridine derivatives." This invention relates to substituted oxopyridine derivatives and processes for their preparation. The compounds developed through her research are intended for use in the production of medicaments aimed at treating and preventing diseases, especially cardiovascular disorders, thrombotic or thromboembolic disorders, and oedemas, as well as ophthalmic disorders. This patent highlights her commitment to addressing critical health issues through innovative solutions.
Career Highlights
Eloisa is currently employed at Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. Her role at Bayer allows her to collaborate with other experts in the field and contribute to groundbreaking research and development projects. Her work has not only advanced her career but has also had a positive impact on the pharmaceutical industry.
Collaborations
Eloisa has worked alongside talented colleagues, including Susanne Röhrig and Karl-Heinz Schlemmer. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions in medicinal chemistry.
Conclusion
Eloisa Jimenez Núnez is a remarkable inventor whose work in medicinal chemistry has the potential to transform the treatment of various diseases. Her patent for substituted oxopyridine derivatives exemplifies her innovative spirit and dedication to improving healthcare outcomes. Through her career at Bayer Pharma Aktiengesellschaft, she continues to make significant contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile